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ABSTRACT
Mycobacterium tuberculosis (Mtb) is a pathogenic bacterium that is the causative
agent of the disease Tuberculosis (TB). TB kills an estimated 1.8 million people
annually and roughly one third of the world’s population carries Mtb in a dormant state.
Drug resistant Mtb strains are on the rise, thus a new method of combating this disease
is paramount. Mtb survival inside of macrophages requires overcoming various
stressors such as; iron restriction, reactive oxygen species, and hypoxic conditions. Mtb
employs the use of catalases, nitric oxide reductase, superoxide dismutase, and
siderophores to aid in survival. These functions have also been found in a novel group
of non-heme diiron binding proteins called hemerythrin-like proteins.

The gene Rv2633c encodes a protein with the hemerythrin-like domain and has
been shown to be upregulated under acidic or nutrient deficient conditions which
coincides with Mtb infection of a macrophage. It has also been shown to be regulated
by PhoP, Whib3, and DosR. In this work we expressed the wild type protein and
several mutants heterologously in E. coli. The purified proteins were studied via UVvisible spectroscopic analysis, native polyacrylamide gel electrophoresis (native-PAGE)
and analyzed for iron content.

Our refined expression and purification protocol led to a significant increase in
soluble protein with a di-iron cofactor. We found that mutagenesis of 11th amino acid, a

ii

histidine, led to the absence of the diiron co-factor. Reduction and autoxidation of
protein was also achieved and characterized through UV-visible absorption. NativePAGE gel analysis indicated only the dimeric form contained iron. This research is the
first to produce large quantities of soluble iron laden protein, demonstrate that Rv2663c
is capable of both reduction and autoxidation, and show it does not bind oxygen in a
functional capacity. This information will enable future studies in protein crystallization,
ligand interaction and in vivo studies.
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CHAPTER 1: INTRODUCTION
Mycobacterium tuberculosis
According to the World Health Organization (WHO), over one-third of the world’s
population is currently infected with Mtb and tuberculosis killed 1.6 million in 2017. The
WHO showed in 2017 an estimated 558,000 new drug resistant cases have emerged
and of those over 80% were multidrug resistant. Mtb is a pathogenic obligate aerobic
bacterium that is the causative agent for the disease Tuberculosis. Mtb has a very thick
and waxy cell wall due to the presence of mycolic wax which helps to give the bacteria a
native resistance due to the difficulty associated with crossing the cell wall. It also
confers an advantage once inside the macrophage, as it serves to aid in acid resistance
and is used by Mtb to arrest the development of the phagolysosome or even evade
engulfment by the macrophage entirely [1-3]. The predominant site of infection is the
lung, as Mtb’s primary route of transmission is through aerosolized droplets[4].

Typically, an Mtb infection starts with the bacteria entering the lung and initiating
the host response where alveolar macrophages are recruited and begin to phagocytize
the bacteria. Once in the macrophage phagosome Mtb stimulates the fusion of the early
endosome fusion to the phagosome through the use of phosphatidylinositol mannoside
(PIM) on its cell wall to [5]. PIM is a precursor to lipoarabinomannan (LAM) which is
used by Mtb to halt the maturation of the phagosome by trafficking LAM to the surface
of the phagosome. LAM is one of the main factors that inhibits the ability of the
1

phagosome to acquire essential factors that lead to the matured endosome [6]. This
enables Mtb to survive in more hospitable conditions compared to the fully developed
phagolysosome [7].

While in the arrested phagosome, Mtb faces other obstacles it must overcome.
One area of concern for the bacteria is the host restriction of iron availability by the
immune response [8]. Iron is an essential nutrient for most forms of life, even though
there are exceptions (such as B. burgdorferi), Mtb must have mechanisms to overcome
this restriction to survive in the host [9]. Mtb utilizes two siderophores to sequester iron
from its host, Myocbactin T and carboxymycobactin [10]. While iron is essential, it can
also be toxic to a cell at high levels. This is because Fe2+ and Fe3+ can undergo Fenton
reactions when hydrogen peroxide is present to from reactive oxygen species which can
damage DNA, RNA, and proteins [11]. For this reason, it is common for aerobic
organisms to have some form of oxidative stress response. Mtb can also use these
responses to combat the reactive oxygen species and nitric oxide reactive species
generated with the macrophage to kill and breakdown the phagocytized bacteria[5, 7,
12]. Mtb uses the WhiB proteins, in a similar manner to OxyR and SoxR in other
bacteria, to regulate its H2O2 and NO response, but it also upregulates DosR
(upregulated but reason is currently unknown [13]) , IdeR, and SigH to regulate
catalase, superoxide dismutase, expression as well[12, 14-16]. Iron-sulfur clusters are
also used to help protect DNA from nitrative stress and have been found in E. coli to be
accompanied by hemerythrin-like domain as a nitric-oxide reductase [13, 17]. While
2

there are identified systems in place for many of the stressors Mtb faces, many of these
functions have also been found in a novel class of proteins known as hemerythrin-like
proteins [18].

All these mechanisms have enabled Mtb to persist and spread across the globe.
With the increase in drug resistance it is imperative to identify new druggable targets.
One such target could be hemerythrin-like proteins, because functions like nitric oxide
reductase, drug susceptibility, and oxygen binding could aid in host survival. Though,
Rv2633c has been shown to not be required for growth, if found to confer a drug
resistance like MSMEG_3312, then inhibiting the function of this protein could be used
as a co-therapy with the given antibiotic [19].

Hemerythrin and Hemerythrin -like Proteins
Hemerythrin and Myohemerythrin
Hemerythrins are a class of protein that, unlike their name suggests, have a nonheme di-iron co-factor, instead of a heme cofactor, that enables the reversible binding of
oxygen[20]. They have a highly conserved iron binding domain (H-HxxxE-HxxxHHxxxD) and are typically octameric or trimeric. Hemerythrin proteins were originally
thought to only be found in the phyla Sipunculid, Pripulida, and Annelida and operate in
the same manner as hemoglobin it those organisms [21, 22]. A similar monomer,
myohemerythrin, is also found in the same phyla and is an oxygen binding protein with
3

high affinity for oxygen and is similar to the myoglobulin in humans [23]. The discovery
of a monomeric hemerythrin in Methylococcus capsulatus, showed that the domain is
not restricted to the three original phyla, as well as the proteins function be restricted
explicitly to oxygen binding [24]. These proteins reversibly bind di-atomic oxygen using
a μ-oxo / μ-hydroxo bridge as shown in Figure 1. The diiron site is also shown to be
coordinated by 5 amino acids on one iron and 6 amino acids on the other. This is
important because only the iron that is cooridnated by 5 amino acids is able to bind the
terminal oxygen.

The ligated iron is found in either a Fe(II)/Fe(II) in the reduced

state, Fe (III)/Fe(II) in the met state, or Fe(III)/Fe(III) in the oxidized state [25, 26].

Figure 1. Hemerythrin u-oxo Bridge

The oxidation of hemerythrin is shown in the figure above. The left side is reduced, and the right
side is oxidized.

Hemerythrin-Like Proteins
Proteins containing hemerythrin motifs and hemerythrin-like proteins are very
diverse among eukaryotes, prokaryotes, and archaea. Hemerythrin-like proteins are
named such because of the derivation from the highly conserved hemerythrin domain
4

[25]. The designation of hemerythrin is only for the proteins/domains that use the HHxxxE-HxxxH-HxxxD to bind the diiron co-factor. Any derivation of this highly conserved
sequence will be considered a hemerythrin-like protein or domain. For example,
Rv2633c has a proposed iron binding domain of H-HxxxE-H-HxxxE and therefore is
known as a hemerythrin-like protein. Another common term used when talking about
these proteins is the general, non-heme diiron carboxylate, nomenclature. Though
caution should be taken when trying to equate the general nomenclature to hemerythrin
and hemerythrin like proteins, as proteins that do not utilize the HHE motif can be
classified as a non-heme carboxylate protein [27]. Even though the proteins are
common among many organisms, the vast majority of the proteins are still
uncharacterized and labeled as hypothetical proteins [18]. Within the past two decades
a few examples of the diverse nature of the hemerythrin domain and hemerythrin-like
proteins have been characterized [28, 29].

While the functions of many hemerythrin-like proteins are still unknown, the ones
that have been characterized have shown a wide array of capabilities and roles in
biological function. In the DcrH protein found in Desulfovibrio vulgaris was found to bind
oxygen using the HxxxE-HxxxH-HxxxD domain of the methyl-accepting chemotaxis
protein using the same 5/6 coordinated diiron center which enables D. vulgaris to avoid
oxygen rich environments [30, 31]. The FBXL5 protein found in humans utilizes a
hemerythrin-like domain to sense the presence of iron. Using the motif H-HExxE-HHxxE, the protein binds iron in a 5/6 coordination. Interestingly the FBXL5 protein is
5

incapable of binding molecular oxygen due to the third glutamic acid in the motif ligating
the 5 coordinated iron under oxidative conditions, it has also been hypothesized that the
variation of the iron radius from Fe(II) to Fe(III) could be used as an oxygen sensor [32].
The Repair of Iron-sulfer Cluster (RIC) protein YtfE in E. coli has been found to not only
bind nitric oxide with its diiron center, but also reduce two moles of nitric oxide to nitrous
oxide and water [17]. YtfE uses a hemerythrin-like domain H-HxxxE-H-HxxxE and has a
5/5 coordinated diiron site. This is a departure from many other hemerythrin like
proteins due to having two 5 coordinated iron sites, which both irons are used to bind
nitric oxide simultaneously which is required for reduction to nitrous oxide [17]. The
gene MSMEG_3312 from Mycobacterium smegmatis encodes a hemerythrin-like
protein that was shown to confer tolerance to erythromycin and is proposed to do so
though reducing the drug. While this has been shown in vivo though knockout and
genomic screening, the team has yet to identify the exact mechanism for this or even
characterize the protein in vitro. Using NCBI conserved domain look-up tool, it proposes
a H-HxxxE-H-HxxxE iron binding motif and this would also indicate a 5/5 coordination of
the diiron site [19, 33]. Some of the hemerythrin-like proteins do not bind iron, but
instead ligates other metals like manganese, as found in the non-heme di-manganese
catalase which has a binding motif of E-ExxH-E-H, though this protein is more like a
ferritin and uses two μ-oxo bridges, making it the outlier when comparing all of the
previous examples. [34].
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The diversity of the functions held by the hemerythrin proteins are due to the iron
binding domain used, the μ-oxo or μ-hydroxo bridge formed, how many amino acids
bind each of the bound irons and the oxidation state of the ligated metal ion [18, 29, 3537]. Typically, the 5/6 coordinated iron hemerythrin’s can exist in one of three states;
reduced, met, or oxidized. In the oxidized state, the penta-coordinated iron is bound to
di-atomic oxygen that is bridged to the connecting μ-hydroxo bridge as shown in Figure
1 [38]. In the met states, the 5C iron is found interacting with H2O or another nonoxygen ligand and is typically labile until it is reduced to a 5 coordinate Fe2+ [38, 39].

With how little is understood with regards to the functions performed by the
hemerythrin and hemerythrin-like proteins, one can understand the need to study these
proteins. The diverse functions that these proteins are capable of can give us further
insight into regulation, sensing, and survival mechanisms that remain elusive to this
day. While studying these proteins, a novel drug target could be found in the form of a
co-therapy. While many of these proteins have been shown to be not required for
growth, it doesn’t mean they do not confer an advantage to survival. As such, removing
that advantage under a given stress, could yield more effective treatments.
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Rv2633c a Hemerythrin-like Protein
Rv2633c is a hemerythrin-like protein found in Mycobacterium tuberculosis (Mtb)
that has been shown to be significantly upregulated during Mtb invasion of a
macrophage, acidic conditions, and nutrient starvation [40, 41]. Rv2633c has also been
shown that it is not essential for growth[42, 43]. While not essential for growth, it has
been shown to cause significant attenuation in mouse models when knocked out via
transposon screenings [44]. This could indicate that the protein is used for survival in
the host macrophage or as a virulence factor. Previous studies of Rv2633c have shown
it to be a homodimer comprised of 18 kDa monomers and each monomer was capable
of binding two molecules of iron. It was also speculated to be comprised of five or six αhelices [45]. It was speculated that the iron cofactors are coordinated by a hemerythrinlike HHE cation binding domain. The presence of a broad absorbance from 300 nm to
360 nm in the UV-visible spectrum indicates that the di-iron sites have a μ-oxo bridge,
which is typical of hemerythrin-like proteins. The study also showed that only
pathogenic and opportunistic pathogenic mycobacteria contain protein homologous to
Rv2633c [46].
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CHAPTER 2: METHODOLOGY
Modeling and Predictions
The use of modeling is required for insight into Rv2633c’s function due to the
lack of a crystal structure from x-ray diffraction. Until one becomes available, all
mutagenesis studies will need to be based on predictive modeling. Initial screening for
protein homologues and all sequence comparisons were conducted using the National
Center for Biotechnology Information’s (NCBI) Basic Local Alignment Search Tool
(BLAST) and NCBI Constraint-based Multiple Alignment Tool (Cobalt) [47]. SWISSMODEL was used for all protein threading and protein database modeling [48].
SnapGene was used to identify 95% conservation in the aligned protein sequences.

The Position Specific Interface (PSI) BLAST allows the user to dictate the E
value, the number of blast hits that are expected to be obtained by chance, for the cutoff
of the BLAST alignment. This allows the alignment to be less stringent when looking for
protein similarity. Only selecting proteins with an E value of less than 0.001, meaning
you would expect to see an alignment 0.001 times by chance, would indicate that the
alignment may be significant and could indicate a conserved biological purpose in the
conserved amino acids. It is also worth noting that BLAST does not identify protein
homology, but merely infers it with a high coverage percentage and low E value. The
default E value cutoff for BLASTp is 1e-6, which is much lower than the PSI BLAST
default E value 0.001 that was used in this study. All protein model visualizations were
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rendered in PyMOL [49]. ProtParam by ExPaSY was utilized to theoretically calculate
the molecular weight and extinction coefficient of Rv2633c.

PCR and Mutagenesis of Rv2633
Plasmid Cloning and Transformation
The original clone of Rv2633c pET-23a(+) was created in the laboratory of Dr.
Kyle Rohde by Mtb genomic amplification and fast cloning into the pET vector. His lab
also transformed them into Rosetta2 expression strain of E. coli. The cloning of all
Rv2633c pET-23a(+) plasmids, both wild-type and mutants, were accomplished using
Invitrogen OneShot TOP10 E. coli competent cells. Subsequent isolation of the DNA
plasmid was accomplished using GeneJET Plasmid Miniprep kit (Thermo Fisher). The
quantification and purity of the isolated plasmids were ascertained using a NanoDrop
Lite (Thermo Fisher).

To generate expression strains for protein purification, plasmids were
transformed via heat shock into the NiCo21(DE3) expression cell line (NEB). The
NiCo21 cell line is derived from the standard BL21 E. coli strain but have been modified
to inhibit common contaminants such as GlmS from binding to the Immobilized Metal
Affinity Chromatography (IMAC) columns [50]. For storage, selected transformants were
grown in 5 mL of LB Amp100 at 37°C overnight. The culture is then mixed with 40%
glycerol (w/v) in a 1:1 ratio and stored in the -80°C for future use.
10

Site-directed Mutagenesis
’Round-the-horn” mutagenesis protocol was used to generate site directed
mutations as previously described [51]. The primer that binds to the 3’-5’ strand
contains the mutation on the 5’ end of the DNA template and is a mismatch to the DNA
codon of the amino acid being mutated. The primers and the melting temperatures (Tm)
used for the PCR protocol developed for H10A, Y54A, E103K, R142A are listed in Table
1. When calculating the Tm for each primer use the New England Biolab’s website for
calculating the Tm for use with the selected polymerase. When using the Q4 polymerase
there is an option for a two-step PCR which can be accomplished if the primers Tm is
around 72˚ C and you can go straight from denaturing to elongation. This protocol is
given by New England Biolabs and has shown to be effective. For oligonucleotide
phosphorylation, the T4 Polynucleotide Kinase (NEB) was used before beginning the
PCR mutagenesis. The PCR products were verified to be the proper size using agarose
electrophoresis (0.1%) agarose gel and visualized using ethidium bromide. After
verification of the mutated plasmid’s size was confirmed, T4 DNA Ligase (NEB) used to
ligate the PCR products overnight at room temperature.

After ligation, the plasmids were then transformed into TOP10 chemically
competent E. coli cells. To verify that correct mutagenesis had occurred, four colonies
from each transformation were isolated and subsequently grown in 5 mL of LB Amp100
11

media overnight. Verification of each mutant plasmid was accomplished though Sanger
sequencing provided by Genewiz.
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Table 1. Rv2633c Mutagenesis Primers
Name

Forward Primer 5’-3’

Annealing
Temperature
(°C)

Reverse Primer 5’-3’

Annealing
Temperature (°C)

H10A

GCGCTTTAATACGTCGTAGGCAT

59

GCACACACCGTGCTTAAAGGACTG

62.7

Y54A

GCACCTGCCCTTTCCGC

71

GTACAGGTCATCCTCGATGCGGA

71

E103K

CAACACGGTCCGGAACACG

57.5

AAGGCGCACGCCGAC

60.5

R142A

CAACTGCTCAATGCGAGCCGC

61.9

CAACTGCTCAATGCGAGCCGC

59.1
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Growth and Purification
Growth Media
For growth of E. coli, Lennox lysogeny broth (LB) (10g tryptophan, 5g yeast
extract, and 5g NaCl per liter) was used. For heterologous expression of Rv2633c
protein, 2 liters of E. coli culture was grown in a 2.8-liter Erlenmeyer flask for all
purifications. For agar plates, the same LB recipe was used with the addition of 15 g of
agar per liter.

Growth and Overexpression of Rv2633c
Both 12-hour and 4-hour growth procedures were used to overexpress the
Rv2633c wild-type and mutant proteins. The following protocols are explicit and if
followed should result in high yields of protein with high levels of iron bound. If NiCo21
E. coli expression strains were used, the only antibiotic needed was 100 mg/L of
ampicillin. If the Rosetta strain was used (provided by Dr. Kyle Rohde), 200 mg/L of
ampicillin and 34 mg/L of chloramphenicol was added after autoclaving the media.
Using a glycerol stock, a 50 mL overnight growth was made using LB with the
applicable antibiotic. The “Starter” culture’s optical density (OD) is measured with after a
1:10 dilution and measured at 600 nm using an Agilent 8453 UV-visible
Spectrophotometer.
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After obtaining the starter culture optical density (OD), an appropriate volume is
added to give a 2 L culture an OD of 0.06 using a simple dilution calculation. After
inoculation the culture was incubated at 37°C while shaking at 220 RPM. Once the
culture had just entered log phase, at an OD of approximately 0.4, the temperature was
reduced to 25° C for the 4-hour growth or 18 °C for the 12-hour growth. At that point the
addition of 1 mM of ferrous ammonium sulfate hexahydrate and 1 mM ferric chloride
was added as a source of iron. Using both irons was found to increase the 340 nm peak
and the iron concentration when compared to ferrous or ferric iron only. This would most
likely be due to utilization of both the FEO iron(II) transport as well as the multiple
iron(III) transports E. coli has. When the OD had reached 0.6, the addition of 0.4 mM
Isopropyl β-D-1-thiogalactopyranoside (IPTG) for 12-hour growth, or 1 mM IPTG for the
4-hour growth, was added to the culture to begin induction. To harvest, the cultures
were centrifuged at 3,000 RCF for 30 minutes at 4 degree Celsius, decanted and pellets
were stored at -80°C for future purification.

Cell Lysis
Frozen cell pellets were weighed and suspended in 50 mL of 50 mM Tris pH 8.0
with 100 mM NaCl and 1 mM benzamidine per 5 g of cell pellet. Typically, this equated
to 50 mL of lysis buffer for every 1 liter of growth. The cell suspension is then lysed via
French press at a cell pressure of 40,000 psi with a flow rate of about 3 drops a second
(or about 4 mL per minute). Crude cell lysates were centrifuged at 25,000 g for 30
minutes and supernatant retained.
15

Cobalt Affinity Chromatography
The primary purification method used for isolation of Rv2633c was IMAC with the
use of either the TALON (GE) or HisPur (Thermo Scientific) cobalt affinity resins. 10 mL
of suspended cobalt resin, which is about 5 mL when packed, was loaded into a 1.5 cm
x 30 cm Econo-column (Bio-rad) which enabled a bed height of about 10 cm of packed
resin. The binding capacity of the Cobalt TALON resin is 10 mg/mL and 15 mg/mL for
the HisPur resin, as stated by the manufacturer. The settings for the Biologic LP
Chromatography System (Bio-Rad) for purification were as follows.

The loading step was accomplished by flowing culture extract, also known as
supernatant, over the cobalt resin with a flow rate of 0.8 mL/min to ensure the ability for
the histidine tagged protein to bind to the column. Loading was conducted while at 4°C
to minimize protease activity and protein denaturation. Figure 2 shows the color change
that occurs when a significant amount of RV2633c protein was loaded onto the IMAC
column. After the protein had bound, the column was then washed with 50 mM Tris pH
8.0 with 100 mM NaCl at a flow rate of 1.0 to 1.5 mL/min to elute non-specifically bound
proteins. Washing continued until the 280 nm absorbance decreased back to zero or 10
column volumes of buffer had been used, if an inline UV detector was not used.
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Figure 2. Cobalt IMAC Column Unbound vs Rv2633c Bound.

The photograph on the left shows the TALON Cobalt IMAC column prior to exposure to
supernatant. The photograph on the right shows the color shift after Rv2633c is bound to resin.

After the initial wash, the column was then further washed using 10 mM
imidazole in 50 mM Tris pH 8.0, 100 mM NaCl. The protein was eluted using a gradient
of imidazole at room temperature. The Bio-Rad LP fast protein liquid chromatography
(FPLC) was used to create the gradient and programed to mix buffer B (500 mM
Imidazole in 50 mM Tris pH 8.0 with 100 mM NaCl) with Buffer A (50 mM Tris pH 8.0
with 100 mM NaCl). The settings for the programed gradient was to go from a 5-17%
buffer B in buffer A over 40 mL at a flow rate of 2.0 mL/min. This was followed by
another gradient from 17-40% buffer B over 50 mL at a flow rate of 0.8 mL/min. This
was followed by 30 mL of buffer B with a flow rate of 0.8 mL/min. Purity of the collected
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fractions was determined through gel electrophoresis using a 12% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel.

Size Exclusion Chromatography
Further purification and buffer exchange of all purified protein was accomplished
through size exclusion chromatography (SEC). First, the collected fractions had to be
concentrated to within 0.5-2% of the total column volume of the SEC column as
specified by manufacture. To concentrate the fractions, a 3,000 molecular weight cutoff
(MWCO) Amicon (Millipore) filter was used in accordance with manufacturer’s
specifications. Superdex 200 (GE) resin was used for the SEC purification in a 2.5 x 30
cm Econo-Column (Bio-rad) and was used in conjunction with the Biologic LP
Chromatography system. All SEC purifications used a standard 50 mM Tris pH 7.5 with
100 mM NaCl buffer that was degassed by sparging argon gas through the buffer for 20
minutes and performed at room temperature. The protein sample was loaded on the
column via gravity loading. Once the sample was loaded on the column the flow rate for
the buffer was set between 0.6 and 0.8 mL/min depending on the packed column size.
Purity of the collected fractions was verified using SDS-PAGE. The elution times were
then used to calculate the size of the protein based on protein standards. The standards
used for 500 mL analytical column were 5 mg/mL of catalase (270 kDa), albumin (66
kDa), carboxylic anhydrase (26 kDa), cytochrome C (12 kDa), and bacitracin (1.4 kDa).
The standards were made in 2 mL of total volume, filtered with a 0.2 μm syringe filter
and gravity loaded.
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SDS-PAGE Gel Electrophoresis
The 4x concentrated resolving layer buffer was made dissolving 36.3 g Tris HCl
in 150 mL ddH2O and the pH was adjusted to 8.8 with concentrated HCl. The mixture
was further diluted to a total volume of 200 mL. Finally, 0.8 g of SDS was added to the
solution and stored at 4° C. The 4x Stacking Layer buffer was made using 3.0 g of Tris
HCl dissolved in 40 mL ddH2O and the pH was adjusted to 6.8 with concentrated
hydrochloric acid. The volume was then brought up to 50 mL with ddH2O.

The 2x loading dye was created by mixing 2.5 mL of the 4x Stacking Layer
buffer, 4.0 mL of a 10% SDS in water solution, 2.0 mL glycerol, 2.0 mg Bromophenol
Blue, 0.31g DTT. The solution was then brought up to 10 mL final volume with the
addition of ddH2O and stored at -20°C. The 10X Tris-glycine pH 8.3 running buffer was
made with 30.3 g Tris HCl, 144.0 g glycine, and 10.0 g SDS dissolved in a total volume
of 1 L with ddH2O and stored at room temperature.

The 12% SDS-PAGE acrylamide gel was made using a 5% stacking layer and
12% resolving layer. The resolving layer was made by mixing 2.5 mL of 4x Resolving
Layer buffer, 4.0 mL of 30% Acrylamide solution (30%:0.8% acrylamide to bisacrylamide mixture in ddH2O), 3.5 mL ddH2O, 100 μL of 100 mg/mL APS solution, and
10 μL of Tetramethylethylenediamine (TEMED). The addition of 100% isopropyl alcohol
on top of the polymerizing layer was used to ensure a level surface was achieved. After
polymerization the 5% stacking layer was made using 1.25 mL of 4x Stacking Layer
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buffer, 0.83 mL of 30% Acrylamide solution, 2.9 mL ddH2O, 50 μL Ammonium
Persulfate (100 mg/mL), and 5 μL TEMED.

When loading purified protein samples, 10 μL of sample was treated with 10 μL
of the 2x Loading Dye and heated at 90°C for 1 minute prior to loading the gel. The
amount of sample was changed to 5 μL when loading cell pellet, supernatant, etc. The
Spectra Multicolor Broad Range Protein Ladder (Fisher) was used as a standard in all
SDS-PAGE gels. The Bio-Rad PowerPAC power supply and Mini-PROTEAN Tetra Cell
were used in all SDS-PAGE electrophoresis protocols. The power supply was set to
constant amps at 35 mA per gel with a time limit of 35 minutes. The gel was then rinsed
with ddH2O and stained with GelCode Blue Protein Stain (Fisher) until bands are visible.
To destain the gel, ddH2O was used overnight.

Protein Characterization
Protein Quantification
Protein quantification was conducted using absorption at 280 nm of a denatured
protein sample. To obtain this, 100 μL of protein sample was mixed in 900 μL of 8 M
guanidine HCl and placed in a 2 mL quartz cuvette. Using the Agilent 8353 UV-visible
Spectrophotometer, the 280 nm absorbance was obtained, and protein concentrations
were calculated using Beer-Lambert’s law. The extinction coefficient for Rv2633c was
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computed with the use of the ExPASy program ProtParam and was calculated to be
12950 M-1 cm-1 and a molecular weight of 18241.78 g/mol.

Iron Analysis: Ferrozine Assay
Ferrozine (Sigma), also known as Sodium 4-[3-pyridin-2-yl-5-(4-sulfophenyl)1,2,4-triazin-6-yl] benzenesulfonate, is colorimetric assay that is commonly used to
quantify the amount of ferrous iron in a solution. The assay has been found previously
to be sensitive down to 4 mg/L of ferrous iron in solution. The complex forms a magenta
color with a peak absorbance at 562 nm, with an extinction coefficient of 27,900 M-1 cm1

[52]. A modified ferrozine assay [53] was used as follows: 200 μL of ~20 μM protein

sample was mixed with 250 μL 0.02% Sodium Ascorbate, 15 μL of concentrated HCl,
and 25 μL of Ferrozine solution (5 mg/mL in ddH2O) and vortexed for 30 seconds.
Subsequently, 1 mL of 8M guanidine HCl and 200 μL saturated Ammonium Acetate
(7.8g ammonium acetate in 10 mL ddH2O) were added to the mixture and allowed to
incubate at room temperature for at least 24 hours. After incubation the 1.69 mL sample
was then loaded into a quartz cuvette and absorbance measured at 562 nm. The
ferrozine assay was carried out in conjunction with protein quantification to ensure
consistency in sample preparation and provide a high level of accuracy when
calculating the ratio of moles of iron to protein. Rv2633c is expected to have a 2:1 ratio
of iron to protein ratio [46].
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Native PAGE and Iron Detection Stain
A 10% to 12% Native-PAGE gel was created using the same protocol as the
SDS-PAGE gels previously mentioned, but without SDS or reducing agents. When
preparing to run the gel, the buffers and gels were allowed to reach 4°C prior to loading
the protein samples. The polyacrylamide gels were made the day of the experiment
each time and never stored. When running a Native-PAGE gel solely for the purpose of
identifying oligomeric states or isoenzymes, no more than 10 μg of protein was loaded
in a 20 μL total volume with a 2:1 ratio of sample to loading buffer.

If the gel was going to be used for detecting iron, then a minimum of 50 μg of
protein was loaded for best visualization as stated for the previously developed protocol
[54]. The protein sample was concentrated, if needed, using a 0.5 mL Amicon (Millipore)
centrifugation filter with a 3 kDa MWCO. 10 μL of the higher concentrated sample (>20
μg/μL) was loaded for better iron visualization. A 5-10 μg sample was also loaded to
enable unobstructed visualization of the oligomeric states of the protein. Finally, for both
types of gels a denatured sample was loaded to identify where the monomeric form
would travel on the gel. In order to denature the sample, the use of the SDS-PAGE
loading buffer was used in place of the Native-SDS page loading buffer.

The SDS in the SDS-PAGE loading buffer was enough to fully denature the
protein without heating, this was found when comparing a previous native gel that had
used head in conjunction with the denaturing loading gel. The gel was run under
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constant voltage set to 90 V for 4 hours at 4°C with enough buffer to cover most of the
casted gel. Running the gel under these conditions decreases the risk of denaturing the
protein due to heat caused by electrophoresis. The gels were run until the loading dye
reached within 2 mm of the bottom of the gel.

Once completed, the Native-PAGE gels that were used for protein visualization
were stained with the GelCode Blue dye used in the SDS-PAGE protocol. For the iron
staining protocol , the gels were washed in ddH2O for 5 minutes. After being rinsed a
100 mM potassium ferricyanide solution was made in ddH2O and mixed until all salts
dissolved. The gels were then incubated with the solution for 10 minutes in the dark, as
the bands formed are photosensitive. When the ferricyanide solution is added, the gel
will be completely yellow, and no bands are visible.

To develop the bands, the ferricyanide solution was decanted and a destain
solution, 10% methanol and 10% trichloroacetic acid in ddH2O, was poured over the gel
and allowed to develop / destain the gel. The solution was replaced until a clear enough
background was achieved, at which point an image was taken using the BioRad
ChemiDoc gel imager. The gel was then soaked in ddH2O to remove the destain
solution, which was followed with the standard protein stain, GelCode Blue.
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Reduction of Rv2633c
The reduction of Rv2633c was accomplished in both an anaerobic and aerobic
environment. The reduction of Rv2633c carried out under anaerobic conditions using a
VAC anaerobic chamber at 1.0-1.5 ppm of oxygen in chamber. The Ocean Optics UVvisible system was used in chamber with a quartz cuvette. Using a 100 μM protein
sample enabled a proper visualization of the 342 nm peak, which is used to monitor
protein reduction. All buffers were degassed with a Schlenk line three times for 15
minutes each under vacuum and then purged with nitrogen.

For the reduction experiment, using the tip of a micro-spatula, sodium dithionite
is added to 2 mL of the Tris buffer and the concentration of dithionite was calculated
using a 1:1000 dilution and absorbance measured at 316 nm. The extinction coefficient
for sodium dithionite is 8000 M-1cm-1 at 316 nm. The starting concentration of stock
sodium dithionite solution should be near 100 mM. 1-2 μL of the stock solution is added
to the 1 mL protein sample resulting in a final concentration of 100-200 μM. Slowly
inverting the cuvette or mixing with pipette will help to rapidly decrease the 316 nm
peak. A fully reduced protein would show a complete reduction in the 342 nm peak.

Reduction was performed in a similar manner outside of the chamber,
aerobically, with a few modifications. To remove the dissolved oxygen in the 50 mM Tris
pH 7.5 with 100 mM NaCl buffer, argon gas was sparged through the buffer for 20
minutes. Around 50 mg of Sodium dithionite was dissolved in 1 mL of the degassed 50
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mM Tris buffer. To reduce the protein 2 μL of 100 mM dithionite stock was added to the
1 mL of 100 mM protein sample and mixing. After allowing the solution to fully
equilibrate, the absorbance was measured and if the 342 nm peak remained more
dithionite was added at 0.5 μL intervals until reduction occurred.
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CHAPTER 3: RESULTS
Modeling and Predictions
NCBI BLAST, Alignments, and Domains
Rv2633c was shown to have a proposed metal binding domain of H-HxxxE-HHxxxE, where the number in parenthesis represents the variable amino acids between
each coordinating amino acid. Several amino acids (H11, H45, E49, H71, H105, and
E109) are completely conserved within the pfam01814 hemerythrin super family, of
which Rv2633c belongs to. When looking at protein alignments, Figure 3, from the Evalue of 10-113 to 2x10-8 shows high conservation of a core set of amino acids. When
compared with the proteins only found in Mycobacteria species, it indicates what amino
acids are required for the protein diiron center ligation and pocket formation, whereas
the later indicates a strong conservation of the C-terminus and could indicate use of the
terminal helices for function in Mycobacteria. The secondary sequence shown in Figure
4, indicates the presence of six alpha-helices. The iron coordinating amino acids are
located on the first four helices, which could indicate that the two C-terminal helices
could be either used to form the dimer, interact with another protein, aid in forming the
binding pocket, or have an amino acid that interacts with the iron that is not accounted
for.
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Figure 3. NCBI BLAST Results

The underlined amino acids are completely conserved over 95% of the time across all
Mycobacterium that have a homologue of this protein. Aligning 65 different organisms, 21 of
which were not Mycobacterium we found 10 perfectly conserved amino acids 100% of the time.
This is denoted using the clustal format where * indicates protein identity was kept, : indicates
similar amino acids are substituted, and . indicates more variance in the amino acids but keeps
its main properties (i.e. charged stays charged and non-polar remains non-polar).

Figure 4. Primary and Secondary Structure Features

This figure shows the predicted iron binding ligands highlighted in red and the underlined
sequence shows alpha-helix predictions using JPRED4.
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Modeling of Rv2633c

Since Rv2633c has never been crystalized for X-ray diffraction studies, the
threading, alignment of primary sequence to the crystal structure, of Rv2633c’s amino
acid sequence was used to elucidate possible protein structures. Using the SWISSMODEL database we identified possible templates for modeling, utilizing the database
scoring for consideration of the models. We then threaded Rv2633c’s sequence through
each of these candidates and the results yielded four templates that had over 70%
coverage of Rv2633c’s primary amino acid structure. All templates used for modeling
were assessed by the SWISS-Model database and assigned both a Global Model
Quality Estimation (GMQE) and Qualitative Model Energy Analysis (QMEAN) score.
These rankings were used to differentiate between acceptable and low-quality model
predictions.

The GMQE score is based on the target-template alignment and is graded from a
0-1, with a score of 1 being the highest possible. The GMQE score is then used to
calculate the QMEAN score, along with calculating possible protein to protein
interactions, torsion caused by bond angles, atom interactions, and solvation
potential[55, 56]. Multiple variables are considered and calculated in each field to find a
distance from the mean and thus provide an overall global quality score. Anything below
a score of -4.0 is considered a poor model and this is based on distance from the mean
of all models in the database. So, in a perfect world a well threaded structure would
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have a GMQE score of 1.0 and a QMEAN score of 0 or higher. The four crystal
structures that Rv2633c was threaded to are shown in Figure 5.

Many of the structures generated did not yield a reliable model and the only
reason the given proteins were used is because of the lack of availability of diverse
crystal structures for hemerythrin-like proteins. Though the models did seem to agree
with the fact that there should be at least 4 alpha helices, which was predicted due to it
being a hemerythrin-like protein. Interestingly both BLAST and SWISS-MODEL were
unable to provide any significant alignment of Rv2633c to proto-typical hemerythrin.
This does bolster the idea that Rv2633c has a different function than hemerythrin.
Between the modeling, primary, and secondary structure alignment, we were able to
produce more meaningful mutagenesis than if we only had the primary and secondary
structures. This experiment has also yielded questions about ligand interactions that will
need to be solved in the future.
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Figure 5. Crystal Structure Models of All Proteins Used in Modeling

This figure shows each of the structures we are modeling to as a comparison reference to what
the threading yielded. In some cases the difference is easily noticeable, looking at FBXL5 for
example, shows how different some of the generated models can be.

Neisseria meningitidis NMB1532 Model

The best model indicated, Figure 6, with a GMQE score of 0.50 and a QMEAN
score of -3.28 was the protein NMB1532 from Neisseria meningitidis. NMB1532 is an
uncharacterized protein with an unknown function that binds two manganese ions and is
a monomer. The threaded model only has an 86% coverage from amino acids 1-138,
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with a sequence identity of 18.38 percent. Figure 6, shows Rv2633c’s predicted
structure and the model does indicate the H11, H45, E49, H71, H105, and E109 amino
acids of the hemerythrin domain coordinate the manganese cations. This structure is
more likely to be accurate than the others based off the scores and the fact that it shows
ligation of two metal ions. Though the alignment of the Rv2633c and NMB1532 show a
high degree of dissimilarity and this could correlate to Rv2633c having a divergent
function or metal ligation than NMB1532. Seeing that this model is the only one to
predict ligation of two metal ions, it was commonly used to identify similarity between
Rv2633c and proteins without known crystal structures.
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Figure 6. Rv2633c Threaded to NMB1532 Protein from Neisseria meningitidis.

The full structure of the model shown in A. The key residue locations with respect to the metal
ligand is depicted in B. Modeling the solvation shell, C, shows a possible binding pocket where
solvation is accessible to the metal ligand and is indicated with a white arrow. The bottom of the
figure shows the alignment of Rv2633c (top) to the threaded structure (bottom). The proposed
metal binding ligands for each is highlighted in the alignment. * = Identity, : = changes to similar
characteristic amino acid, and . = amino acid substitution with less similar amino acids but retain
some characteristics.
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Human FBXL5 Protein Model

The model generated by FBXL5, Figure 7, has a GMQE score of 0.45 and a
QMEAN score of -3.89. The proteins sequence identity to Rv2633c is 19.85% with a
coverage of 82% from amino acids 4-136. While a typical FBXL5 protein binds two
molecules of iron, the model generated indicated that Rv2633c would only bind one iron
molecule using H11, H45, E49, E49, E109 to do so. The model indicated the oligomeric
state to be a monomer. When comparing this to the actual FBXL5 structure Figure 5, it
can plainly be seen how different this model is and therefore not a very good
representation. The lack of consistent alpha-helices and not binding two metal ligands
also detracts from the feasibility of the model generated. This could indicate that the
structure/function of Rv2633c is not consistent with the FBXL5 protein, though it must
be noted that the FBXL5 protein is a much larger protein than the hemerythrin-like
domain shown and that could influence the structure.
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Figure 7. Rv2633c Threaded to Human FBXL5 Protein.

The full structure of the model shown in A. The key residue locations with respect to the metal
ligand is depicted in B. Modeling the solvation shell, C, shows a possible binding pocket where
solvation is accessible to the metal ligand and is indicated with a white arrow. The bottom of the
figure shows the alignment of Rv2633c (top) to the threaded structure (bottom). The proposed
metal binding ligands for each is highlighted in the alignment. * = Identity, : = changes to similar
characteristic amino acid, and . = amino acid substitution with less similar amino acids but retain
some characteristics.
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Escherichia coli YtfE Protein Model

The YTFE model, Figure 8, is a monomer with a GMQE score of 0.42 and a
QMEAN score of -3.71 with a sequence identity of 16.10% and a coverage of 74% from
amino acids 2-119. It shows amino acids H45, E49, H71, and E109 coordinating a zinc
molecule. This model was considered invalid for only one metal ligand being portrayed
and the QMEAN score being very close to the cut off. Though it does seem that the only
major difference in iron binding between the two proteins is in the primary alpha helices
where an iron ligating histidine is located. This could also mean that the threading
alignment would not align and that is why only one metal is shown. The iron
coordination of YtfE matching Rv2633c’s proposed coordination would indicate the
possibility of Rv2633c binding nitric oxide and should be studied in the future.

35

Figure 8. Rv2633c Threaded to Iron-Sulfur Cluster Repair Protein YTFE from
Escherichia coli.

The full structure of the model shown in A. The key residue locations with respect to the metal
ligand is depicted in B. Modeling the solvation shell, C, shows a possible binding pocket where
solvation is accessible to the metal ligand and is indicated with a white arrow. The bottom of the
figure shows the alignment of Rv2633c (top) to the threaded structure (bottom). The proposed
metal binding ligands for each is highlighted in the alignment. * = Identity, : = changes to similar
characteristic amino acid, and . = amino acid substitution with less similar amino acids but retain
some characteristics.
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Comparison of Rv2633c and MSMEG_3312 in NMB1532 Models

MSMEG_3312 is a gene that encodes for a hemerythrin-like protein that is found
in the same Pfam as Rv2633c. Since both proteins lacked a crystal structure, the
structures were compared using a common model threaded to Figure 9. The selection
of the protein NMB1532 was because it was scored the highest for both proteins and
they had similar GMQE and QMEAN scores. Both proteins showed using the
coordinated HHEHHE domain to bind the manganese ions. Even though SMEG3312
has the domain spaced Hx(32)xHxxxEx(25)xHx(33)xHxxxE, it still lines up with
Rv2633c’s Hx(33)xHxxxEx(21)xHx(33)xHxxxE domain which could indicate a similar
ligand or function. Though there is no discernable homology detected using BlastP,
there is homology shown in the clustal alignment. Like YtfE, the first iron binding
histidine does not align. The close similarity could indicate a similar function or ligand
interaction.
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Figure 9. Rv2633c and SMEG3312 Threaded N. meningitidis

The alignment of the Rv2633c (Magenta) and SMEG3312 (Blue) models that have been
threaded to the N. meningitidis protein NMB1532 show structural similarity (A). The coordinating
amino acids are shown for Rv2633c (red label) and SMEG3312 (white label) (B) to be in almost
the exact same location as Rv2633c when threaded. The proposed metal binding ligands for
each is highlighted in the alignment. * = Identity, : = changes to similar characteristic amino acid,
and . = amino acid substitution with less similar amino acids but retain some characteristics.
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Mutagenesis
Based on the models generated by SWISS-MODEL, BLAST alignments, and
secondary structures, we were able to narrow down our mutant selections to H10A,
Y49A, E103K, and R142A. The H10A mutant was chosen to identify which amino acid
ligates the iron, also because the H11A mutant was already created by Michael Boring
and it gives credibility to the BLAST results where it proposed H11 was an amino acid
that interacted with iron. Y49A was chosen because the tyrosine was proposed to be
within 4 angstroms of the iron binding site, indicating it could be used in the function of
Rv2633c and mutation could lead to altered substrate binding activity once found.
E103K mutation was generated because it is one amino acid away from a proposed iron
binding residue and the polarity change from glutamic acid to lysine could alter the
binding site. If the protein were found to be an enzyme that alteration to the binding site
could give insight to the binding pocket of Rv2633c. Finally, the mutant R142A was
generated to investigate the effects of mutagenesis on the C terminus of Rv2633c and
as a mutation that is not in the N-terminus like the others and if they failed there would
be a higher chance this one could produce soluble protein.

All mutants were successfully created and transformed into the NiCo21 E. coli
expression strain and stored with 20% glycerol in the -80°C. The confirmation of the
mutants is shown below in Figure 10 based on Sanger sequencing of a clone from the
Round the horn mutagenesis protocol. Using the ferrozine assay to identify iron
concentrations we found that the H11A mutant rendered the Rv2633c protein unable to
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bind iron. The H10A mutant was capable of binding iron, but it seemed to hinder the iron
binding capability due to the reduced iron content when compared to wildtype. The
remaining mutations (Y49A, E103K, and R142A) did not yield soluble protein after
multiple attempts, though it should be noted that these mutants were never purified with
the improved purification protocol and therefore should be readdressed in the future
using the tuned expression system.

Figure 10. Mutagenesis Confirmation Alignment

The alignments above show the verified mutant alignments from GeneWiz.
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Growth and Purification
Over the past two years several variations for protein overexpression and
purification of both wild type RV2633c and mutant proteins have been carried out.
Alterations in expression time, temperature, strain and lysis procedures were carried out
to optimize the protein production. The data presented in this M.S. thesis will pertain to
the 2019 purifications, as those preparations yielded the highest amount of soluble
protein and had high levels of iron present. Previous preparations would typically yield
only 5 mg of protein for an entire purification, yet the most recent purification with the
highest yield of purified protein was over 80 mg of wild type RV2633c in a 4-liter growth.
This was the result of systematic changes in various purifications throughout 2017 and
into 2018. Though the last two purifications 5-25 and 5-26, had far lower iron
incorporation than the 2-22-19 did and this is likely due to 1mM ferric chloride not being
added during induction. It could also be due to the huge increase in soluble protein
yielded or the use of the TALON IMAC resin. It should also be noted that the vast
decrease in the production yields was partly due to deviation from my initial protocol to
try and purify higher amounts of the protein and fear that it was being damaged in my
purification methods. We later found out that it was unfounded and began growing and
purifying as we initially had with the modification to include 1mM ferrous ammonium
sulfate hexahydrate to maximize the amount of iron available. Going forward I would
recommend adding a second round of iron addition at the 6-hour induction point, as I
fear that the low ratio of iron to protein is due to the loss of iron availability. This would
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occur from either E. coli using it for other essential proteins or oxidation of the iron and
it precipitates out of solution.

Both the NiCo21 and Rosetta strains of E. coli produced high levels of soluble
protein with iron present. A 4-hour induction of a 4-liter growth with 1 mM IPTG would
typically yield 10 to 12 grams of wet cell pellet. The 12-hour growth with 0.4 mM IPTG
yielded a 22 grams of wet cell pellet. When using the French press a 3 drop per second
flow rate gave over 50% lysis in one pass, which is verified by comparing pre-lysis and
post-lysis samples after spinning at 3000 rcf for 10 minutes.
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Figure 11. Cobalt IMAC Purification SDS-PAGE

The SDS-PAGE shows the IMAC Purification and the level of contamination found in the
collected fractions. This is a 12% SDS-PAGE using Tris-Glycine running buffer and is from the
3-Mar-19 H10A Purification.

Rv2633c protein consistently elutes from the Cobalt IMAC purification column
between 60 and 100 mM imidazole. The protein purity after IMAC was not ideal, as
shown in Figure 11, and required further purification. This is most likely due to the
elution of the protein with low imidazole concentrations and E. coli having many
histidine rich proteins that can contaminate the column.

The 26-May-19 cobalt IMAC fractions shown in Figure 12, were eluted with 60
mM imidazole and had the most visible color of any protein preparation to date. The red
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colored fractions were pooled together and concentrated for further S200 size exclusion
purification. Unfortunately, several attempts to produce the Y54A, E103K, and R142A
mutants did not yield soluble protein from affinity chromatography.

Figure 12. Wildtype High Yield Affinity Purification

The image above is from the 25-May-19 Rv2633c wildtype affinity purification. The protein
began to elute from column around 60 mM Imidazole in 50 mM Tris pH 8.0 with 100 mM NaCl.

Size exclusion chromatography using Superdex 200 resin indicated the wildtype
protein has a predicted molecular weight of 34 kDa. The H10A mutant eluted after 288
mL indicating a size of 36 kDa. The apparent size of H11A could not be calculated via
this method because the column that was used for purification changed for this analysis,
and no standards were available. The alignment of the SEC purifications for 4-Apr-19
wildtype and 2-Mar-19 H10A are shown in Figure 13. The purified fractions were pooled
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together, aliquoted and snap frozen. The absorbance of soluble preparations that were
SEC purified are shown in Figure 14.

Figure 13. Size Exclusion Chromatography with Protein Standard

The graph shows the travel time for both H10A and Wildtype Rv2633c on an analytical SEC
column. The S200 Standard is as follows; 1. catalase (270 kDa), 2. albumin (66 kDa), 3.
carboxylic anhydrase (26 kDa), 4. cytochrome C (12 kDa), and 5. bacitracin (1.4 kDa). The void
volume is shown at peak 1 and in H10A is a large peak due to a lot of contaminants in the
purification due to the inability to wash the column well.
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Figure 14. Rv2633c Wildtype SEC Purified UV-visible Spectrum

This graph shows the absorbance spectra from 260 to 450 nm for each S200 purified protein at
its concentration when aliquoted. The characteristic peak at 342 nm indicates the presence of a
μ-oxo bridge[32].

Rv2633c Wildtype and Mutant Characterization
UV-visible Characterization and Protein Concentration Quantification
Representative scans of the H11A, H10A, and WT proteins are shown in Figure
15. One notable aspect of H11A is the lack of the 342 nm peak that is present in both
H10A and wild type. Table 2 shows the results from the protein quantification, ferrozine
assay, and UV-visible spectrum analysis. The 13-Apr-19 purified wildtype is missing iron
quantification due to not having ferrozine at the time. The data in the table shows that
while we had a massive increase in soluble protein recovered, it did not have a high
concentration of iron present. This is most likely due to two factors, the first being not
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using ferric chloride and the second it being a much higher increase in protein, there is
the possibility that the iron present in the media was reduced to less than optimal levels
for iron incorporation. If Rv2633c requires iron to be present at the time of folding and
there is none, it could account for the high level of apo protein in those two purifications.
It was also found that using 0.4 mM IPTG yielded far more soluble protein than the 1
mM IPTG. In fact, 0.4 mM IPTG yielded more soluble protein than 0.1 mM IPTG did as
well, though the 1mM IPTG caused the formation of inclusion bodies, whereas 0.1 IPTG
just created less protein. The mutation H11A does in fact show that there is no iron
present, and this shows that Rv2633c also requires both iron molecules to bind in order
to bind any iron at all. The H10A mutant did bind iron but in a depreciated capacity, this
could be due to the alteration of the binding pocket, the alteration of the position of the
histidine at position 11, or a poor purification. Seeing as H10A only yielded soluble
protein once and H11A twice, it would be hard to infer if the H10A reduction was due to
the mutation or the purification. Though both purifications of H11A yielded protein in its
apo form. The ratio of 280 nm to 340 nm also tells us about the iron presence and it
seems to indicate that the closer we are to a 3:1 ratio, the closer we get to 100%
occupancy. We have in fact never seen anything below a 3:1 ratio and for this reason I
would say that 3:1 would be an optimal value for said ratio. The lack of consistent iron to
protein ratios above a 1:1 is not a call for concern, as Hemerythrin-like proteins typically
have a low isolated iron concentration. Hence the 2-22-19 purification being a bench
mark for others to follow.
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Figure 15. Purified Mutants vs Wildtype

Representatives of each purifications are shown in comparison to each other. All samples are in
50 mM Tris pH 7.5 with 100 mM NaCl. These scans have been conducted more than 20 times
for each listed protein. Though it should be noted, that while the wild-type did have many
successful yields, H11A had only two and H10A one.

Table 2. Protein Quantification and Ferrozine Analysis
Protein
Protein Sample Concentration
(μM)
WT 8-4-18 188
WT 2-22-19 36
WT 4-13-19 35.44
WT 5-25-19 279
WT 5-26-19 320
H10A 3-1-19 36
H11A 3-3-19 33

Iron
Concentration
(μM)
164
69
Unavailable
102
209
38
3
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Iron to Protein
Ratio (Optimal;
2:1)
0.87:1
1.9:1
Unavailable
0.37:1
0.65:1
1:1
0.09:1

280 : 342 ratio
10.31:1
3.8:1
3.26:1
12:1
5.9:1
7.33:1
No 342 Present

Native-PAGE and Iron Staining
The 10% Native-PAGE resolved the bands well and enabled clear view of the
proportion of Rv2633c in each oligomeric state. The gel in Figure 16 indicates the
possibility of monomers, dimers, and potentially trimers. Though the existence of the
trimer has not been confirmed through SEC, only the dimer and monomer have.
Through overlaying the same gel stained for iron using the ferricyanide staining method
and the protein stained gel, iron presence is obtained. The bands were boxed to help
visualize the iron location; a non-colorized version of the iron stained gel is found in
Figure 17. It should be noted that the standard ladder can not be considered accurate
due to the lack of SDS in the native gel. Also, the smearing of the lanes is quite typical
of native gels and for this reason some people avoid using them, but when coupled with
a selective staining technique, it is quite a powerful option. As it shows which oligomeric
state your protein has cofactor and you can screen for many reactive oxidative species
through various staining methods. This is a way to positively show your protein is what
the activity is attributed to.
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Figure 16. A Native SDS Polyacrylamide Gel Detecting Presence of Iron

The image above shows an overlay of a native SDS gel stained with ferricyanide to detect the
presence of iron and the same gel stained with GelCode Blue to visualize protein. The boxed
bands identify the iron positive bands. The stained gel’s color was inverted to help visualize the
faint bands of the Iron Staining gel.
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Figure 17. Iron Stained Native-PAGE Gel

The image shows what the iron stained gel without being overlaid the protein gel and no color
correction.

Reduction of Rv2633c Wildtype
The full reduction of wild type Rv2633c, shown in Figure 18, is indicated with the
loss of the 342 nm peak absorbance. Reduction has been achieved in both aerobic and
anaerobic conditions, with the difference being that Rv2633c will stay reduced in the
anaerobic chamber with only 5 ppm oxygen. The amount of dithionite needed for
reduction in an aerobic environment is about 2 mM, but as soon as it is reduced it will
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begin to oxidize and it can be difficult to not overload the spectrum with the dithionite
316 nm absorbance. While in the anaerobic chamber with properly degassed buffers, it
only took 170 μM dithionite, which would be enough to reduce 340 μM of iron because
each mole of dithionite is able to generate two reduction potentials. The UV-visible
spectrum was monitored for 20 minutes to ensure that the 342 nm peak did not return
after reduction. The peak rapidly oxidized within seconds when it was exposed to
oxygen.

Figure 18. Reduction and Reoxidation of Rv2633c Wildtype

This spectrum shows the complete reduction and reoxidation of Rv2633c in 50 mM Tris pH 7.5
with 100 mM NaCl using 170 μM sodium dithionite. The black line just after 280 nm is an artifact
from using the Ocean Optics Spectrophotometer.
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CHAPTER 4: DISCUSSION
With Mtb currently infecting one-third of the world population and a reported
increase in drug resistance by the WHO, novel ways to combat the bacteria has
become much needed. One possible group of proteins that may provide a novel
druggable target are hemerythrin-like proteins. While many are uncharacterized, the
functions of the known are highly diverse and typically are associated with growth and
survival [18]. In Mtb the gene Rv2633c, encoding for a hemerythrin-like protein, was
found to be upregulated upon Mtb being phagocytized by the alveolar macrophage, acid
stress and during times of starvation [40, 41]. While it has been shown not to be
essential for Mtb survival, the fact Rv2633c is upregulated upon entrance into the
macrophage could indicate it to be a virulence or survival factor [44].

The di-iron center was solidified by using the ferrozine assay and showed up to
1.9 moles of iron per mole of protein. This knowledge aided our study and allowed us to
eliminate poorly assembled protein models. The presence of a metal cation cofactor
eliminates the PF0695 threaded model, even though it’s GMQE and QMEAN scores
indicated a stronger model [56]. The YtfE and FBXL5 models should also not be
considered feasible due to the lack of a di-iron cofactor and the tertiary structure
predicted does not indicate the full use of the HHEHHE domain. This leaves the
NMB1532 Protein model from Neisseria meningitidis, which has a di- metal cofactor that
are bound by the predicted H11, H45, E49, H71, H105, and E109 amino acids. It also
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has acceptable GMQE and QMEAN values and therefore is the most likely
representation of Rv2633c of the models generated by SWISS-Model.

The refined purification protocol developed during this study has enabled an
immense increase in soluble protein, with two molecules of iron per molecule of protein,
yielded from purification. The ability to obtain high levels of soluble protein with iron
presence has been very difficult both in our study and previous studies [45, 46]. The key
difference in yield from the growth and expression protocols was likely the addition of
iron salts at the time of induction and growing two liters of culture in a 2.8 liter flask at a
reduced temperature. Using both 1 mM ferrous ammonium sulfate hexahydrate and
1mM ferric chloride at the time of induction showed much higher concentrations of iron
in the purified protein, as opposed to only using ferrous ammonium sulfate. It should be
noted that the use of any phosphate buffer is not compatible with metal proteins due to
its chelating ability and will yield low amounts of metal incorporation. The reduced iron
content of the 5-26-19 could be due to two factors; first being the use of only 1 mM
ferrous ammonium sulfate hexahydrate and the second being the amount of protein that
was created. In future expressions of Rv2633c it may prove beneficial to induce with
both iron salts and then add more iron midway through the growth. Considering that this
is not a natural production of this protein, high levels of iron are required to have proper
incorporation into the protein, and even then it is not guaranteed. This is one of the
downsides to using recombinant gene expression to overexpress a protein for
purification. Between the 5-26-19 and 5-25-19 growths using the NiCo21 strain of E.
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coli, showed that the highest yield of soluble protein was with a 12-hour growth at 18 °C
and induced with 0.4 mM IPTG.

The characterization of the H11A mutant demonstrated the direct correlation
between the presence of iron in the protein and the 342 nm peak presence. The lack of
iron being present in the protein indicates the 11th amino acid in the Rv2633c sequence,
a histidine, is required for metal binding. This experiment demonstrates the requirement
that both irons must be present in the active site for the protein to coordinate the iron.
This is logical because of the two bridging carboxylates, used to stabilize the di-iron
center, have been shown in hemerythrin-like proteins to each bind both irons [32]. The
H10A mutation shows that mutation of residues flanking a ligating H11 will not
completely inhibit the binding of iron, but it does seem to indicate it made iron binding
less capable. Further, these experiments show that Rv2633c is soluble in its apo form. If
Rv2633c can bind iron in its apo form to transition to its holo form, could indicate a
possible function as a sensor. Though future studies would need to take place where
iron (II) is added in highly reduced environment, such as a glove box with 5 ppm oxygen
or less to avoid oxidation of the iron. This experiment should also be ran with adding
iron (III) while in the chamber, to see if there is a binding preference to oxidation state.
After iron addition it would be beneficial to take a before and after sample and run them
on a native gel or SEC to identify any changes in the oligomeric state. If iron addition is
not possible, it should be able to dialyze the iron out of the protein under reduced
conditions with buffer that has low amounts of ethylenediaminetetraacetic acid to
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chelate the iron out. This would also help identify a possible answer to the question
posed by the iron stained native gel, where it seems that the dimeric form is the iron
bound form of the protein.

We have previously shown Rv2633c to exist as a dimer in a published study,
though our current study shows multiple oligomeric states [46]. Figure 16 clearly shows
three different oligomeric states; a monomer, dimer, and even trimer/tetramer. These
findings when coupled with Native-PAGE gel iron staining shows that the dimeric state
of Rv2633c has a higher iron concentration. When comparing the bands of the protein
levels in the monomer and dimer sites, they appear to be in similar concentrations, yet
there is no iron stained band where the monomer is. While the assay used is not very
sensitive due to the amount of iron required to develop a band, it still does not account
for the fact that similar concentrations of protein do not have the same or similar results.
To further investigate these findings, it would be best to isolate the various oligomeric
states through size exclusion chromatography and run a ferrozine assay on fully
separated fractions where native gels would be used to verify oligomeric state purity.
Another reason for the multiple oligomeric states could be due to protein degradation or
misfolding and therefore the use of mass spectroscopy could be used to identify any
variances in mass that could be attributed to degradation. The findings from the nativePAGE gel are substantial due to the previously unknown existence of multiple
oligomeric states. This coupled with the iron staining shows that the dominant iron
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binding oligomeric state is a dimer and calls into question if the other oligomeric states
are functions of the protein or is it due only to misfolding.

Another finding of this study was the ability to fully reduce Rv2633c, which had
been initially stated as being resistant to reduction [46]. This is significant because
studies have shown that hemerythrin proteins may require reduction in order to interact
with their functional ligands [38]. Being able to reduce the protein will enable future
studies in protein-ligand interactions, as well as characterize the reduction potential of
Rv2633c. This experiment also showed that Rv2633c does not bind oxygen as a ligand,
this can be extrapolated by the lack of a 500 nm peak, that has been shown in
hemerythrin’s that bind oxygen, after reduction and allowed to autoxidize. This is
another key difference in Rv2633c from oxygen binding hemerythrin proteins, the time
for autoxidation for Rv2633c is seconds, whereas oxygen binding hemerythrin proteins
is usually around 10 minutes or more [20, 31, 38]. This effectively concludes that
Rv2633c does not bind diatomic oxygen in an end-over-end fashion using a μ-hydroxo
bridge

The results and findings of this thesis have shown novel insight into the
characterization of Rv2633c. Using the expression protocol developed during this
research could enable future crystallography studies to further understand the structure
of the Rv2633c protein. Future in vivo studies using iron restricted growth in
combination with chromatin immunoprecipitation and subsequent protein sequencing
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could identify if Rv2633c can interact with DNA or if it can bind to a protein that can in
turn interact with DNA to regulate transcription and thus show Rv2633c is a sensor.
Mutation of Mtb genomic DNA to include the H11A that has been shown to inhibit metal
ligand binding would benefit knock-out studies of Rv2633c by comparing genetic
expression changes in WT, H11A, and knock-out mutants. Finally, ligand screening for
Rv2633c can be conducted with respect to typical ligands, such as nitric oxide, azide,
ferricyanide and other common adducts to scan for possible interactions. This will be
paramount to finally understand what the function of Rv2633c is and why it is
upregulated in the macrophage. While it is not a guarantee that the identification of
Rv2633c’s function will lead to new breakthroughs in Mtb treatment, it will undoubtedly
bring some understanding to a novel class of proteins whose purpose is largely
unknown and it is this quest of knowledge that will ultimately be satiated in these future
studies.
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